These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 186621)

  • 41. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
    Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Replication of Epstein-Barr virus primary infection in human tonsil tissue explants.
    Gotoh K; Ito Y; Maruo S; Takada K; Mizuno T; Teranishi M; Nakata S; Nakashima T; Iwata S; Goshima F; Nakamura S; Kimura H
    PLoS One; 2011; 6(10):e25490. PubMed ID: 21998663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers.
    Pegtel DM; Middeldorp J; Thorley-Lawson DA
    J Virol; 2004 Nov; 78(22):12613-24. PubMed ID: 15507648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Responses of gibbons to inoculation of Epstein-Barr virus.
    Werner J; Pinto CA; Haff RF; Henle W; Henle G
    J Infect Dis; 1972 Dec; 126(6):678-81. PubMed ID: 4351976
    [No Abstract]   [Full Text] [Related]  

  • 45. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
    Allday MJ; MacGillivray AJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Cancer Sci; 2008 Aug; 99(8):1633-42. PubMed ID: 18754877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus (EBV) infection by cocultivation of fibroblast-dominant cell line and EBV-transformed lymphocytes.
    Furukawa M; Kamide M; Miwa T; Sakumoto M; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(2):69-76. PubMed ID: 2540473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A study of Epstein-Barr virus susceptibility in human tonsil B lymphocyte subpopulations].
    Harabuchi Y; Yamanaka N
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1799-811. PubMed ID: 2833594
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils.
    Ikeda T; Kobayashi R; Horiuchi M; Nagata Y; Hasegawa M; Mizuno F; Hirai K
    J Gen Virol; 2000 May; 81(Pt 5):1211-6. PubMed ID: 10769062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus DNA is present both in CD10/CD77 positive and negative subsets of human tonsillar lymphocytes.
    Cirone M; De Maria R; D'Alessandro A; Frati L; Faggioni A; Ragona G
    Cancer Lett; 1995 Feb; 89(1):125-8. PubMed ID: 7882294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus.
    Zhang RD; Henderson EE
    Virology; 1994 Feb; 198(2):709-13. PubMed ID: 7507284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
    PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.
    Miller G; Lipman M
    J Exp Med; 1973 Dec; 138(6):1398-412. PubMed ID: 4357683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
    Hinuma Y; Sakamoto K
    IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human monoclonal antibodies to viral peptides.
    Sidorova E; Borisova T; Lyakisheva L; Rosen A
    Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of Epstein-Barr virus and interleukin 6 in the development of lymphomas of human origin in SCID mice engrafted with human tonsillar mononuclear cells.
    Nadal D; Albini B; Schläpfer E; Bernstein JM; Ogra PL
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():113-21. PubMed ID: 1309857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.